RecruitingCerebral Aneurysm
Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objective of this study is to explore the effects of Sirolimus on the underlying molecular alterations of cerebral aneurysms.
Sponsor: University of Miami
You may qualify if…
- ✓ 1. Undergoing one of the following procedures at Jackson Memorial Hospital:
- ✓ Clipping of an unruptured cerebral artery aneurysm
- ✓ Endovascular treatment of unruptured cerebral aneurysms (including those receiving coiling)
- ✓ 2. ≥ 18 years of age
- ✓ 3. Willing and able to give informed consent
You may not qualify if…
- ✕ 1\) Subjects meeting any of the following criteria will be excluded:
- ✕ Dissecting, traumatic, or mycotic brain aneurysm.
- ✕ Women who are pregnant, or have a positive urine or blood (β-hCG) pregnancy test.
- ✕ Women who are breastfeeding.
- ✕ Any clinically significant psychiatric or psychological disease, which would preclude the patient from completing the protocol.
- ✕ Patients with known Human Immunodeficiency Virus (HIV) infection or other known immunodeficiency.
- ✕ Patient with renal or liver failure
- ✕ Interstitial pneumonitis
Where it's recruiting
Florida
Miami
Source: ClinicalTrials.gov · NCT04141020 · last updated 2026-03-23